Clínica Médica
Suplemento | Síndrome do intestino irritável e condições relacionadas.
28 Jan, 2022 | 15:09hPágina principal: IBS and Related Conditions – Alimentary Pharmacology and Therapeutics
Review article: epidemiology of IBS and other bowel disorders of gut–brain interaction (DGBI)
Review article: Physical and psychological comorbidities associated with irritable bowel syndrome
Review article: Diagnosis and investigation of irritable bowel syndrome
Review article: current and future treatment approaches for IBS with constipation
Review article: current and future treatment approaches for pain in IBS
Estudo randomizado | CPAP melhora os desfechos em pacientes com insuficiência respiratória hipoxêmica aguda decorrente de COVID-19, mas cateter nasal de alto fluxo não é melhor que a oxigenoterapia convencional.
25 Jan, 2022 | 15:10hEditorial: Defining Optimal Respiratory Support for Patients With COVID-19 – JAMA
Comentário no Twitter
RCT of patients with acute hypoxemic respiratory failure due to #COVID19 found an initial strategy of CPAP, compared with conventional oxygen therapy, significantly reduced the composite outcome of tracheal intubation or mortality within 30 days. https://t.co/fznFigiFmu pic.twitter.com/b7mHssbfkp
— JAMA (@JAMA_current) January 24, 2022
Breve revisão ACP | Risco de reinfecção após contágio pelo SARS-CoV-2.
25 Jan, 2022 | 15:07h
Comentário no Twitter
Risk for Reinfection After #SARSCoV2: previous infection reduced risk for reinfection by 87% (95% CI, 84% to 90%). Protection remained above 80% for at least 7 months, but no study followed patients after the emergence of the Delta or #Omicron variant. https://t.co/eruEf1w8Vo
— Prof. Nick Talley (@Prof_NickTalley) January 25, 2022
OMS deixa de se opor aos reforços de vacina – recomenda a terceira dose da Pfizer para adultos e 2 doses de vacinas para crianças a partir de 5 anos de idade.
25 Jan, 2022 | 15:06hConteúdos relacionados:
WHO updated roadmap for prioritizing uses of COVID-19 vaccines.
WHO advisers weigh in on COVID-19 boosters, Pfizer vaccine in younger kids.
Um estudo de caso-controle mostrou risco aumentado de miocardite após vacinação contra COVID-19 com vacina mRNA em comparação com vacina de vírus inativado.
25 Jan, 2022 | 15:04hComunicado de imprensa: BNT162b2 COVID-19 vaccine associated with increased risk of carditis – American College of Physicians
Conteúdos relacionados:
[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.
Heart-inflammation risk from Pfizer COVID vaccine is very low.
Avaliação inicial da gravidade clínica da variante Ômicron do SARS-CoV-2 na África do Sul.
25 Jan, 2022 | 15:02hComentário: Omicron severity: milder but not mild – The Lancet
Comentário no Twitter
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in S. Africa, Lancet. Individuals with Omicron vs previous infections 80% lower odds of being admitted to hospital, 70% lower odds of severe disease than Deltahttps://t.co/528NWfKrDN
— Monica Gandhi MD, MPH (@MonicaGandhi9) January 23, 2022
[Preprint] Estudo de coorte | Risco reduzido de internação associado com infecção pela variante Ômicron do SARS-CoV-2 em relação à variante Delta.
25 Jan, 2022 | 15:01hComentários:
Danish report: lower risk of hospitalisation with Omicron – Copenhagen Post
Comentário no Twitter
New Danish population-based cohort study confirms lower (36%, 95%CI 44%-25%) risk of hospitalization with Omicron compared with Delta.
The risk also seems to be reduced irrespective of vaccination status.Pre-print can be found here: https://t.co/LfRrw1H3CY pic.twitter.com/Ql3zPyZyRE
— Anders Husby (@a_husby) January 20, 2022
[Preprint] A variante Ômicron do SARS-CoV-2 está associada com risco reduzido de internação e permanência em hospital, em comparação com a variante Delta.
25 Jan, 2022 | 14:59h
Comentário no Twitter
In Portugal, Omicron hospitalizations were 75% reduced compared with Delta, risk adjusted. Vaccination reduced hospitalizations 84%, w/a booster 93%https://t.co/MvkfuF3mzx pic.twitter.com/zyk2INWNis
— Eric Topol (@EricTopol) January 23, 2022